Capricor’s data clash and a fugitive in the C-suite
Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their companies? Find out on the latest episode of "The…
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
